The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Symetryx Corp since 2023.
This trader's CIK number is 1991925.
At the time of last reporting, Symetryx Corp was the 10% Owner of Neubase Therapeutics, Inc.. (stock ticker symbol NBSE).
Also see all insider trading activities at Neubase Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | NBSE | 61,076 | $59,732 | 489,520 | $712,348 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-18 | NBSE | Sale | 50,000 | 1.19 | 59,500 |
| 2023-09-15 | NBSE | Sale | 103,337 | 1.26 | 130,204 |
| 2023-09-14 | NBSE | Sale | 129,108 | 1.44 | 185,915 |
| 2023-09-07 | NBSE | Sale | 74,852 | 1.80 | 134,733 |
| 2023-09-11 | NBSE | Sale | 3,376 | 1.44 | 4,861 |
| 2023-09-08 | NBSE | Sale | 128,847 | 1.53 | 197,135 |
| 2023-09-01 | NBSE | Buy | 61,076 | .98 | 59,732 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Symetryx Corp (10% Owner of Neubase Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.